IPCALAB

• In our previous update in July 2023, we mentioned that stock’s corrective phase could be over, and it is a Value Buy.
  
• In October 2023, the stock cleared its potential resistance level around 900 along with MACD crossing above Trigger line.
  
• This confirmed continuation of long term up-move.
  
• Price is now initially expected to test 2535, with optimistic targets extending to 3700 and 5555.